X. Castellsagué
The Lancet Oncology · 2002–2016
A researcher in the Science corpus: 20 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom X. Castellsagué trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts X. Castellsagué overall
Papers from X. Castellsagué's perspective
Ordered by how strongly the researchers X. Castellsagué trusts endorse each paper. Same corpus, a different order for every researcher.
- HPV screening for cervical cancer in rural India. (New England Journal of Medicine)
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. (Vaccine)
- Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. (Journal of the National Cancer Institute)
- Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. (Journal of the National Cancer Institute)
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. (The Lancet Oncology)
- Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. (Vaccine)
- Sexual behaviour in context: a global perspective. (The Lancet)
- Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. (Vaccine)
- J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- The papillomavirus life cycle. (Journal of Clinical Virology)
Their papers
- Genome-wide meta-analyses identify multiple loci associated with smoking behavior (2010) — 1,140 citations
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. (2016) — 747 citations
- HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. (2016) — 675 citations
- HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. (2014) — 666 citations
- A review of clinical trials of human papillomavirus prophylactic vaccines. (2012) — 754 citations
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. (2012) — 631 citations
- Worldwide burden of cervical cancer in 2008. (2011) — 1,104 citations
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. (2010) — 2,506 citations
- Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. (2010) — 1,633 citations
- Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the INHANCE consortium (2009) — 1,100 citations
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. (2009) — 1,578 citations
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. (2007) — 1,688 citations
- Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. (2007) — 1,357 citations
- Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. (2006) — 707 citations
- Chapter 1: HPV in the etiology of human cancer. (2006) — 1,398 citations
- Against which human papillomavirus types shall we vaccinate and screen? the international perspective (2004) — 1,271 citations
- Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. (2003) — 664 citations
- Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. (2003) — 1,288 citations
- Epidemiologic classification of human papillomavirus types associated with cervical cancer. (2003) — 6,445 citations
- Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. (2002) — 821 citations